Novel medical technologies and drug platforms such as mRNA and lipid nanoparticles are revolutionizing healthcare, with applications in such critical areas as cancer treatment, rare diseases, and novel vaccines. We are honored to have join us today three recipients of the international Tang Prize in Biopharmaceutical Science, awarded for their role in developing mRNA vaccines, to examine what the future holds for these exciting new technologies. Join us for a thought-provoking and informative session on the cutting edge of drug development technologies.

The Asia Pacific region has become a hotbed of biotech investment. This session will explore the latest trends and opportunities in this space, with a special focus on Taiwan. Hear from industry leaders on the factors driving investment in the region, the challenges and opportunities for startups, and the outlook for future growth. We’ll also examine Asia’s role as a major clinical trials hub, and the latest innovations and best practices for conducting efficient and effective trials. Join our expert speakers as they examine the fast-evolving regulatory landscape, the impact of digital technologies, and the potential for new approaches to improve patient outcomes.

The biotech industry is increasingly global in scope, with international collaboration considered an essential element for success. This session will delve into the strategies and best practices for collaboration between multinational companies and local partners, and examine the challenges and opportunities that arise from cross-border partnerships. Gain an understanding of how multinational companies can support Taiwan's precision healthcare development goals, including the sharing of resources, expertise, and infrastructure. We’ll also explore the clinical trial ecosystem, focusing on the latest trends and innovations in trial design and implementation, and highlighting the importance of collaboration between academia, industry, and regulatory bodies.

This session will focus on the key factors to successfully launching new products onto world markets; technology, utilizing AI, for example; reimbursement, understanding both policy and current practices; patient diversity; and economics, including tapping investment and capital markets. Speakers will share experience and insights on navigating regulatory environments, managing clinical trials, and addressing the needs of patients and stakeholders. The session will also highlight the latest innovations in drug development, such as precision medicine and digital health technologies, and the potential for these approaches to improve patient outcomes and streamline the drug development process. Attendees can expect to gain valuable insights into what it takes for successful global drug development.

Despite the challenging capital market environment of 2022, the Asian biotech and healthcare sector demonstrated resilience and even growth, significantly outperforming the main indices in markets across the greater Asian region. However, in a cautious investment environment, biotech companies must look to alternative funding sources to support research-intensive programs. This session has assembled top Asian investment bankers and financial professionals from leading institutions to discuss capital funding strategies and future opportunities and challenges for the biotech industry across Asia. Speakers include senior representatives from Goldman Sachs, Citigroup, and NASDAQ. Join us for an enlightening discussion on biotech investing for 2024 and beyond.

With the theme of " Crossing Borders, Establishing a Global Biotech Ecosystem", this luncheon aims to explore how to establish a comprehensive innovative environment that helps foster innovation and accelerate cross-disciplinary cooperation. At the same time, this environment will also facilitate the latest global R&D trends and connect global supply chains to support the breakthrough of emerging technologies. For the biotechnology and medical industries, which are closely related to the welfare of human beings, immediate actions to connect innovation and CDMO resources should be implemented.
At this session, international start-ups and CDMO supportive networks, including AIT, Johnson & Johnson, New Deantronics, Ernst & Young, ITRI and others, will be invited to share their successful experiences in their ventures as well as their global supply chain cooperation cases. It is hoped that this event initiates constructive conversations and brings more diversified perspectives to all parties involved.

As global regulatory authorities are winding down the path to expedited reviews for coronavirus-related subjects, life science companies are urged to follow their traditional regulatory paths to market. Without a doubt, uncertainty remains elevated and creates a dramatic impact on global economies. Life science companies must continue to differentiate themselves by formulating strategies with broader and more rigorous approaches to stay agile and create value. Across biotech and healthcare industries, Asia is becoming critically important to the global life science ecosystems. Taiwan sits right in the epicenter of this Asia ecosystem and establishes itself as a trusted hub for biotechnology. Taiwan offers significant advantages in life science R&D such as high-quality medical data, a deep well of scientific and biomedical talents for conducting clinical trials, drug discovery, advanced diagnostics, and a booming life science capital market.

This session will explore the latest developments and innovations at the intersection of precision health and clinical medicine. Examine the latest diagnostic tools and technologies driving the uptake of precision health, including next-generation sequencing for identifying treatment targets. Participants can expect to gain a deeper understanding of the ways in which precision health is transforming clinical practice and healthcare overall, and learn about the latest developments in moving from trial to treatment. This is a must-attend session for anyone looking to stay at the forefront of the rapidly evolving precision health landscape.

This session will showcase the latest novel biotech platforms from around the world. Speakers from both academia and industry will explore the cutting-edge technologies and platforms that are changing the game, from next-generation gene editing tools to revolutionary new drug delivery systems. Attendees can expect to gain a deeper understanding of the latest developments in biotech research and innovation, and learn about the most promising new platforms. Stay ahead of the curve and explore the latest advances that are driving biotech research and innovation to new heights. Don’t miss out on this must-attend session!

Explore the latest and most promising new therapeutic modalities that are transforming healthcare today. Discover exciting new therapies as well as the latest drug development innovations; including gene and cell therapies, RNA-based therapies, and next-generation biologics. Learn from our panel of leading industry experts from Asia and around the world as they examine the latest trends, developments and future possibilities in therapeutics.

Digital health is a rapidly growing field with the potential to transform the way we approach healthcare. In this session, speakers will discuss the latest developments in digital health infrastructure development with a particular focus on Asia, and how these advancements are paving the way for a future of personalized, data-driven healthcare across the region. Understand the disruptive potential of the digital health revolution, and gain insights into the latest trends and emerging technologies that are shaping the industry. Whether you're a medical professional, investor, or simply interested in the future of healthcare in Asia and beyond, this session is for you.

With Asia a fast-growing global CDMO hub, we’ll deep dive into the latest trends, opportunities, and challenges facing the biomedical supply chain and contract manufacturing industries. Expert speakers will share their knowledge and experience in navigating complex regulatory landscapes, improving manufacturing processes, and enhancing supply chain resilience and agility. Whether you're a biotech industry professional, a healthcare provider, or an investor, this session offers a unique opportunity to stay up-to-date on the latest developments and best practices in supply chain and bio-manufacturing.

Don't miss this exciting session on the future of medtech! Our expert speakers will explore the latest health-tech innovations, and discuss strategies for connecting with innovators from across the APAC community. Gain valuable insights into emerging medical technology trends and opportunities, from the latest breakthroughs in devices to cutting-edge digital health solutions. With a focus on collaboration and cross-border partnerships, this session offers a unique opportunity to connect with industry leaders and explore new pathways to success in this dynamic and rapidly evolving industry. Get ready to be inspired, empowered, and energized as you explore the limitless potential of the medtech revolution!